Literature DB >> 19410685

Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease).

Herbert B Tanowitz1, Fabiana S Machado, Linda A Jelicks, Jamshid Shirani, Antonio C Campos de Carvalho, David C Spray, Stephen M Factor, Louis V Kirchhoff, Louis M Weiss.   

Abstract

Chagas disease is caused by the parasite Trypanosoma cruzi. It is a common cause of heart disease in endemic areas of Latin America. The year 2009 marks the 100th anniversary of the discovery of T cruzi infection and Chagas disease by the Brazilian physician Carlos Chagas. Chagasic cardiomyopathy develops in from 10% to 30% of persons who are chronically infected with this parasite. Echocardiography and magnetic resonance imaging (MRI) are important modalities in the evaluation and prognostication of individuals with chagasic heart disease. The etiology of chagasic heart disease likely is multifactorial. Parasite persistence, autoimmunity, and microvascular abnormalities have been studied extensively as possible pathogenic mechanisms. Experimental studies suggest that alterations in cardiac gap junctions may be etiologic in the pathogenesis of conduction abnormalities. The diagnosis of chronic Chagas disease is made by serology. The treatment of this infection has shortcomings that need to be addressed. Cardiac transplantation and bone marrow stem cell therapy for persons with Chagas disease have received increasing research attention in recent years.

Entities:  

Mesh:

Year:  2009        PMID: 19410685      PMCID: PMC2677559          DOI: 10.1016/j.pcad.2009.02.001

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  101 in total

Review 1.  An update on Chagas disease (human American trypanosomiasis).

Authors:  A Moncayo; M I Ortiz Yanine
Journal:  Ann Trop Med Parasitol       Date:  2006-12

Review 2.  Coronary microvascular abnormalities in Chagas' disease.

Authors:  M A Rossi; S G Ramos
Journal:  Am Heart J       Date:  1996-07       Impact factor: 4.749

3.  Chagas' heart disease diagnosed on MRI: the importance of patient "geographic" history.

Authors:  Constantin B Marcu; Aernout M Beek; Albert C van Rossum
Journal:  Int J Cardiol       Date:  2007-02-22       Impact factor: 4.164

Review 4.  The role of endothelin in the pathogenesis of Chagas' disease.

Authors:  S B Petkova; H Huang; S M Factor; R G Pestell; B Bouzahzah; L A Jelicks; L M Weiss; S A Douglas; M Wittner; H B Tanowitz
Journal:  Int J Parasitol       Date:  2001-05-01       Impact factor: 3.981

5.  Brain natriuretic peptide based strategy to detect left ventricular dysfunction in Chagas disease: a comparison with the conventional approach.

Authors:  Antonio Luiz P Ribeiro; Mauro M Teixeira; Adelina M Reis; Andre Talvani; Amanda A Perez; Márcio Vinicius L Barros; Manoel Otávio C Rocha
Journal:  Int J Cardiol       Date:  2005-07-14       Impact factor: 4.164

6.  Tissue-specific oxidative imbalance and mitochondrial dysfunction during Trypanosoma cruzi infection in mice.

Authors:  Jian-Jun Wen; Monisha Dhiman; Elbert B Whorton; Nisha Jain Garg
Journal:  Microbes Infect       Date:  2008-07-16       Impact factor: 2.700

7.  A 9,000-year record of Chagas' disease.

Authors:  Arthur C Aufderheide; Wilmar Salo; Michael Madden; John Streitz; Jane Buikstra; Felipe Guhl; Bernardo Arriaza; Colleen Renier; Lorentz E Wittmers; Gino Fornaciari; Marvin Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-06       Impact factor: 11.205

8.  Effects of early and late verapamil administration on the development of cardiomyopathy in experimental chronic Trypanosoma cruzi (Brazil strain) infection.

Authors:  Andrea P De Souza; Herbert B Tanowitz; Madhulika Chandra; Vitaliy Shtutin; Louis M Weiss; Stephen A Morris; Stephen M Factor; Huan Huang; Murray Wittner; Jamshid Shirani; Linda A Jelicks
Journal:  Parasitol Res       Date:  2004-03-04       Impact factor: 2.289

9.  Abnormalities of the coronary microcirculation in acute murine Chagas' disease.

Authors:  S M Factor; S Cho; M Wittner; H Tanowitz
Journal:  Am J Trop Med Hyg       Date:  1985-03       Impact factor: 2.345

10.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.

Authors:  Charles E Murry; Mark H Soonpaa; Hans Reinecke; Hidehiro Nakajima; Hisako O Nakajima; Michael Rubart; Kishore B S Pasumarthi; Jitka Ismail Virag; Stephen H Bartelmez; Veronica Poppa; Gillian Bradford; Joshua D Dowell; David A Williams; Loren J Field
Journal:  Nature       Date:  2004-03-21       Impact factor: 49.962

View more
  67 in total

1.  New drugs for neglected infectious diseases: Chagas' disease.

Authors:  Fabiana S Machado; Herbert B Tanowitz; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

2.  Trypanosoma cruzi infection results in the reduced expression of caveolin-3 in the heart.

Authors:  Daniel Adesse; Michael P Lisanti; David C Spray; Fabiana S Machado; Maria de Nazareth Meirelles; Herbert B Tanowitz; Luciana Ribeiro Garzoni
Journal:  Cell Cycle       Date:  2010-04-15       Impact factor: 4.534

3.  Crucial role of the central leptin receptor in murine Trypanosoma cruzi (Brazil strain) infection.

Authors:  Fnu Nagajyothi; Dazhi Zhao; Fabiana S Machado; Louis M Weiss; Gary J Schwartz; Mahalia S Desruisseaux; Yang Zhao; Stephen M Factor; Huan Huang; Chris Albanese; Mauro M Teixeira; Philipp E Scherer; Streamson C Chua; Herbert B Tanowitz
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

4.  In vitro and in vivo trypanocidal effects of the cyclopalladated compound 7a, a drug candidate for treatment of Chagas' disease.

Authors:  Alisson L Matsuo; Luis S Silva; Ana C Torrecilhas; Bruno S Pascoalino; Thiago C Ramos; Elaine G Rodrigues; Sergio Schenkman; Antonio C F Caires; Luiz R Travassos
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

5.  Two approaches to discovering and developing new drugs for Chagas disease.

Authors:  J H McKerrow; P S Doyle; J C Engel; L M Podust; S A Robertson; R Ferreira; T Saxton; M Arkin; I D Kerr; L S Brinen; C S Craik
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

Review 6.  Gap junctions and chagas disease.

Authors:  Daniel Adesse; Regina Coeli Goldenberg; Fabio S Fortes; Dumitru A Iacobas; Sanda Iacobas; Antonio Carlos Campos de Carvalho; Maria de Narareth Meirelles; Huan Huang; Milena B Soares; Herbert B Tanowitz; Luciana Ribeiro Garzoni; David C Spray
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

7.  High fat diet aggravates cardiomyopathy in murine chronic Chagas disease.

Authors:  Kezia Lizardo; Janeesh Plakkal Ayyappan; Min-Hui Cui; Rashmi Balasubramanya; Linda A Jelicks; Jyothi F Nagajyothi
Journal:  Microbes Infect       Date:  2018-07-31       Impact factor: 2.700

8.  Chagas Cardiomyopathy in New Orleans and the Southeastern United States.

Authors:  Robert C Hsu; Joshua Burak; Sumit Tiwari; Chayan Chakraborti; Gary E Sander
Journal:  Ochsner J       Date:  2016

Review 9.  Pathology and Pathogenesis of Chagas Heart Disease.

Authors:  Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

10.  The absence of myocardial calcium-independent phospholipase A2γ results in impaired prostaglandin E2 production and decreased survival in mice with acute Trypanosoma cruzi infection.

Authors:  Janhavi Sharma; Christopher S Eickhoff; Daniel F Hoft; David A Ford; Richard W Gross; Jane McHowat
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.